HuGE Literature Finder
Records
1
-
13
| Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing Study. Clinical and translational gastroenterology 2021 Oct 12 (10): e00414. Uson Pedro L S, Samadder N Jewel, Riegert-Johnson Douglas, Boardman Lisa, Borad Mitesh J, Ahn Daniel, Sonbol Mohamad B, Faigel Douglas O, Fukami Norio, Pannala Rahul, Kunze Katie, Golafshar Michael, Klint Margaret, Esplin Edward D, Nussbaum Robert L, Stewart A Keith, Bekaii-Saab Tani |
| Re-evaluating cancer risks associated with the CHEK2 p.Ser428Phe Ashkenazi Jewish founder pathogenic variant. Familial cancer 2021 Oct . Laitman Yael, Nielsen Sarah M, Hatchell Kathryn E, Truty Rebecca, Bernstein-Molho Rinat, Esplin Edward D, Friedman Eit |
| Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2019 Dec . Goldstein Jennifer B, Zhao Li, Wang Xuemei, Ghelman Yael, Overman Michael J, Javle Milind, Shroff Rachna T, Varadhachary Gauri R, Wolf Robert A, McAllister Florencia, Futreal P Andrew, Fogelman David |
| Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma. International journal of cancer 2019 Jan . Obazee O, Archibugi L, Andriulli A, Soucek P, Malecka-Panas E, Ivanauskas A, Johnson T, Gazouli M, Pausch T, Lawlor R T, Cavestro G M, Milanetto A C, Di Leo M, Pasquali C, Hegyi P, Szentesi A, Radu C E, Gheorghe C, Theodoropoulos G E, Bergmann F, Brenner H, Vodickova L, Katzke V, Campa D, Strobel O, Kaiser J, Pezzilli R, Federici F, Mohelnikova-Duchonova B, Boggi U, Lemstrova R, Johansen J S, Bojesen S E, Chen I, Jensen B V, Capurso G, Pazienza V, Dervenis C, Sperti C, Mambrini A, Hackert T, Kaaks R, Basso D, Talar-Wojnarowska R, Maiello E, Izbicki J R, Cuk K, Saum K U, Cantore M, Kupcinskas J, Palmieri O, Fave G Delle, Landi S, Salvia R, Fogar P, Vashist Y K, Scarpa A, Vodicka P, Tjaden C, Iskierka-Jazdzewska E, Canzian |
| Association between homologous recombination repair gene mutations and response to oxaliplatin in pancreatic cancer. Oncotarget 2018 Apr 9 (28): 19817-19825. Kondo Tomohiro, Kanai Masashi, Kou Tadayuki, Sakuma Tomohiro, Mochizuki Hiroaki, Kamada Mayumi, Nakatsui Masahiko, Uza Norimitsu, Kodama Yuzo, Masui Toshihiko, Takaori Kyoichi, Matsumoto Shigemi, Miyake Hidehiko, Okuno Yasushi, Muto Mana |
| The Prevalence of Founder Mutations among Individuals from Families with Familial Pancreatic Cancer Syndrome. Cancer research and treatment : official journal of Korean Cancer Association 2017 Apr 49 (2): 430-436. Lener Marcin R, Kashyap Aniruddh, Kluzniak Wojciech, Cybulski Cezary, Soluch Agnieszka, Pietrzak Sandra, Huzarski Tomasz, Gronwald Jacek, Lubinski J |
| Do founder mutations characteristic of some cancer sites also predispose to pancreatic cancer? International journal of cancer 2016 Mar . Lener Marcin R, Scott Rodney J, Klu?niak Wojciech, Baszuk Piotr, Cybulski Cezary, Wiechowska-Koz?owska Anna, Huzarski Tomasz, Byrski Tomasz, K?adny Józef, Pietrzak Sandra, Soluch Agnieszka, Jakubowska Anna, Lubi?ski J |
| Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia. Cancer 2015 Dec . Churpek Jane E, Marquez Rafael, Neistadt Barbara, Claussen Kimberly, Lee Ming K, Churpek Matthew M, Huo Dezheng, Weiner Howard, Bannerjee Mekhala, Godley Lucy A, Le Beau Michelle M, Pritchard Colin C, Walsh Tom, King Mary-Claire, Olopade Olufunmilayo I, Larson Richard |
| Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015 Oct . Hu Chunling, Hart Steven N, Bamlet William R, Moore Raymond M, Nandakumar Kannabiran, Eckloff Bruce W, Lee Yean K, Petersen Gloria M, McWilliams Robert R, Couch Fergus |
| CHEK2 gene alterations in the forkhead-associated domain, 1100delC and del5395 do not modify the risk of sporadic pancreatic cancer. Cancer epidemiology 2010 Oct 34 (5): 656-8. Mohelnikova-Duchonova Beatrice, Havranek Ondrej, Hlavata Ivona, Foretova Lenka, Kleibl Zdenek, Pohlreich Petr, Soucek Pav |
| Is there any relationship between BRCA1 gene mutation and pancreatic cancer development? Polskie Archiwum Medycyny Wewn?trznej 2008 Nov 118 (11): 645-9. Lawniczak Ma?gorzata, Gawin Alicja, Bia?ek Andrzej, Lubi?ski Jan, Starzy?ska Tere |
| Single-nucleotide polymorphisms of DNA damage response genes are associated with overall survival in patients with pancreatic cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Apr 14 (7): 2042-8. Okazaki Taro, Jiao Li, Chang Ping, Evans Douglas B, Abbruzzese James L, Li Dongh |
| Low frequency of CHEK2 mutations in familial pancreatic cancer. Familial cancer 2006 5 (4): 305-8. Bartsch Detlef K, Krysewski Kristina, Sina-Frey Mercedes, Fendrich Volker, Rieder Harald, Langer Peter, Kress Ralf, Schneider Margarete, Hahn Stephan A, Slater Emily |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 16, 2022
- Content source: